View all staff
Doctor Jonathan Shepherd

Dr Jonathan Shepherd

 PhD
Principal Research Fellow

Connect with Jonathan

Email: Jonny.Shepherd@soton.ac.uk

Tel: +44 23 8059 7055

ORCID
Publications External roles and responsibilities
Publications External roles and responsibilities

Publications

98 publications
Page 1 of 10
An economic evaluation of local anaesthetic transperineal biopsy in people with suspected prostate cancer
Ines Ribeiro, Lois Woods, Emma Maund, David Alexander Scott, Joanne Lord, Jo Picot & Jonathan Shepherd, 2024
Type: conference
PARP inhibitors for metastatic urothelial carcinoma: a systematic review of efficacy and safety
Simon J. Crabb, Taha Khalid, Lois Woods, Geoff Frampton & Jonathan Shepherd, 2023, Bladder Cancer, 9(4), 365-376
DOI: 10.3233/BLC-230071
Type: review
Darolutamide with androgen deprivation therapy and docetaxel for treating hormone-sensitive metastatic prostate cancer
Lorna Hazell, Keith Cooper, Fay Chinnery, Karen Pickett, David Alexander Scott & Jonathan Shepherd, 2023
Type: report
Patient decision support resources inform decisions about cancer susceptibility genetic testing and risk management
Kelly Kohut, Kate Morton, Lesley Turner, Jonathan Shepherd, Vicky Fenerty, Lois Woods, Chloe Grimmett, Diana M. Eccles & Claire Foster, 2023, Frontiers in Health Services, 3, 1092816
DOI: 10.3389/frhs.2023.1092816
Type: article
Polatuzumab vedotin in combination for untreated diffuse large B-cell lymphoma
Emma Maund, Keith Cooper, Marcia Tomie Takahashi & Jonathan Shepherd, 2022
Type: report
Avalglucosidase alfa for treating Pompe disease
Ines Ribeiro, Emma Maund, Keith Cooper, Karen Pickett, Marcia Tomie Takahashi, David Alexander Scott & Jonathan Shepherd, 2022
Type: report
Nintedanib for treating idiopathic pulmonary fibrosis in people with a forced vital capacity above 80% predicted (part-review of technology appraisal guidance 379)
Keith Cooper, Lorna Hazell, Asyl Hawa, Joanna Picot, Fay Chinnery, David Alexander Scott & Jonathan Shepherd, 2022
Type: report
Atezolizumab for untreated PD-L1 positive locally advanced or metastatic urothelial cancer when cisplatin is unsuitable (CDF review TA492): a single technology appraisal
Keith Cooper, Karen Pickett, Ines Ribeiro, David Alexander Scott & Jonathan Shepherd, 2021
Type: report
Bimekizumab for treating moderate to severe chronic plaque psoriasis
Lorna Hazell, Joanne Lord, Neelam Kalita, David Alexander Scott & Jonathan Shepherd, 2021
Type: report
Tucatinib with trastuzumab and capecitabine for treating HER2-positive unresectable locally advanced or metastatic breast cancer after 2 or more anti-HER2 therapies - A Single Technology Appraisal
David Alexander Scott, Lorna Hazell, Jill L. Colquitt, Neelam Kalita, Joanne Lord, Emma Loveman & Jonathan Shepherd, 2021
Type: report
How to edit profile